Review



blocking anti-human tlr2 monoclonal antibodies  (Cascade BioScience)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cascade BioScience blocking anti-human tlr2 monoclonal antibodies
    Blocking Anti Human Tlr2 Monoclonal Antibodies, supplied by Cascade BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blocking anti-human tlr2 monoclonal antibodies/product/Cascade BioScience
    Average 90 stars, based on 1 article reviews
    blocking anti-human tlr2 monoclonal antibodies - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    anti human tlr2 blocking monoclonal antibody  (Novus Biologicals)
    90
    Novus Biologicals anti human tlr2 blocking monoclonal antibody
    Quantitative analysis of immunohistochemical staining
    Anti Human Tlr2 Blocking Monoclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human tlr2 blocking monoclonal antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    anti human tlr2 blocking monoclonal antibody - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    anti-human tlr2 blocking monoclonal antibody, clone tl2.1  (Novus Biologicals)
    90
    Novus Biologicals anti-human tlr2 blocking monoclonal antibody, clone tl2.1
    Quantitative analysis of immunohistochemical staining
    Anti Human Tlr2 Blocking Monoclonal Antibody, Clone Tl2.1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human tlr2 blocking monoclonal antibody, clone tl2.1/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    anti-human tlr2 blocking monoclonal antibody, clone tl2.1 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    blocking monoclonal anti-human/mouse cd282 tlr2 purified antibody clones t2.5 and 6c2  (Thermo Fisher)
    90
    Thermo Fisher blocking monoclonal anti-human/mouse cd282 tlr2 purified antibody clones t2.5 and 6c2
    Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b <t>monoclonal</t> antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).
    Blocking Monoclonal Anti Human/Mouse Cd282 Tlr2 Purified Antibody Clones T2.5 And 6c2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blocking monoclonal anti-human/mouse cd282 tlr2 purified antibody clones t2.5 and 6c2/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    blocking monoclonal anti-human/mouse cd282 tlr2 purified antibody clones t2.5 and 6c2 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    anti-human tlr2 blocking monoclonal antibody (mab) t2.5 clone, isotype migg1  (Thermo Fisher)
    90
    Thermo Fisher anti-human tlr2 blocking monoclonal antibody (mab) t2.5 clone, isotype migg1
    Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b <t>monoclonal</t> antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).
    Anti Human Tlr2 Blocking Monoclonal Antibody (Mab) T2.5 Clone, Isotype Migg1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human tlr2 blocking monoclonal antibody (mab) t2.5 clone, isotype migg1/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    anti-human tlr2 blocking monoclonal antibody (mab) t2.5 clone, isotype migg1 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    blocking anti-human tlr2 monoclonal antibody tl2.1  (Thermo Fisher)
    90
    Thermo Fisher blocking anti-human tlr2 monoclonal antibody tl2.1
    Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b <t>monoclonal</t> antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).
    Blocking Anti Human Tlr2 Monoclonal Antibody Tl2.1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blocking anti-human tlr2 monoclonal antibody tl2.1/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    blocking anti-human tlr2 monoclonal antibody tl2.1 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    a blocking anti-human tlr2 monoclonal antibody (tl2.1)  (Thermo Fisher)
    90
    Thermo Fisher a blocking anti-human tlr2 monoclonal antibody (tl2.1)
    Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b <t>monoclonal</t> antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).
    A Blocking Anti Human Tlr2 Monoclonal Antibody (Tl2.1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a blocking anti-human tlr2 monoclonal antibody (tl2.1)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    a blocking anti-human tlr2 monoclonal antibody (tl2.1) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    blocking anti-human tlr2 monoclonal antibodies  (Cascade BioScience)
    90
    Cascade BioScience blocking anti-human tlr2 monoclonal antibodies
    Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b <t>monoclonal</t> antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).
    Blocking Anti Human Tlr2 Monoclonal Antibodies, supplied by Cascade BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blocking anti-human tlr2 monoclonal antibodies/product/Cascade BioScience
    Average 90 stars, based on 1 article reviews
    blocking anti-human tlr2 monoclonal antibodies - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Quantitative analysis of immunohistochemical staining

    Journal: Indian Journal of Dermatology

    Article Title: Immunohistochemical Analysis of Differences of Toll-Like Receptor 2, Mast Cells, and Neurofilaments between Granulomatous Rosacea and Non-Granulomatous Rosacea

    doi: 10.4103/ijd.IJD_18_20

    Figure Lengend Snippet: Quantitative analysis of immunohistochemical staining

    Article Snippet: The following antibodies (Ab) were used for immunohistochemistry: anti-human TLR2 blocking monoclonal antibody, clone TL2.1 (Novus Biologicals, Littleton, CO, USA), anti-human neurofilmanet (NF) proteins L/H (2F11) blocking monoclonal antibody, sc-52350 (Novus Biologicals, Littleton, CO, USA), and anti-human mast cell (MC) tryptase (G3) blocking monoclonal antibody, sc-33676 (Santa Cruz Biotechnology, Texas, USA).

    Techniques: Immunohistochemical staining, Control

    Localization of MCs, NFs, and TLR2 in control, ETR-, GR-type facial skin as shown by immunohistochemistry. Arrows indicate positive cells in each immunohistochemistry staining. ETR: Erythematelagiectatic rosacea. GR: Granulomatous rosacea. MC: Mast cell trypatase. NF: Neurofilament. TLR2: Toll-like receptor 2

    Journal: Indian Journal of Dermatology

    Article Title: Immunohistochemical Analysis of Differences of Toll-Like Receptor 2, Mast Cells, and Neurofilaments between Granulomatous Rosacea and Non-Granulomatous Rosacea

    doi: 10.4103/ijd.IJD_18_20

    Figure Lengend Snippet: Localization of MCs, NFs, and TLR2 in control, ETR-, GR-type facial skin as shown by immunohistochemistry. Arrows indicate positive cells in each immunohistochemistry staining. ETR: Erythematelagiectatic rosacea. GR: Granulomatous rosacea. MC: Mast cell trypatase. NF: Neurofilament. TLR2: Toll-like receptor 2

    Article Snippet: The following antibodies (Ab) were used for immunohistochemistry: anti-human TLR2 blocking monoclonal antibody, clone TL2.1 (Novus Biologicals, Littleton, CO, USA), anti-human neurofilmanet (NF) proteins L/H (2F11) blocking monoclonal antibody, sc-52350 (Novus Biologicals, Littleton, CO, USA), and anti-human mast cell (MC) tryptase (G3) blocking monoclonal antibody, sc-33676 (Santa Cruz Biotechnology, Texas, USA).

    Techniques: Control, Immunohistochemistry, Staining

    Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b monoclonal antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).

    Journal: Applied and Environmental Microbiology

    Article Title: Piliation of Lactobacillus rhamnosus GG Promotes Adhesion, Phagocytosis, and Cytokine Modulation in Macrophages

    doi: 10.1128/AEM.03949-14

    Figure Lengend Snippet: Role of CD11b in adhesion and uptake of L. rhamnosus GG by RAW 264.7 cells and effect of TLR2 in the subsequent immunomodulatory response. (A) Role of CD11b in adhesion of the mutants to macrophages (left) and phagocytosis of the mutants by macrophages (right) relative to the results for the wild-type strain, which were set equal to 1. Bacterial strains (5 × 107 CFU/ml) were coincubated for 1 h with 1 × 106 RAW 264.7 cells that had previously been treated with anti-mouse CD11b monoclonal antibody (5 μg/ml) for 30 min. The data are presented as the mean relative adhesion or phagocytosis ± standard deviation. These experiments were done in triplicate. Asterisks represent statistically significant differences compared to the results for the controls (no antibody treatment). (B) The effect of TLR2 on the relative levels of IL-10 and IL-6 mRNA expression by RAW 264.7 macrophages was analyzed by pretreatment of macrophages with antibodies against TLR2 (5 to 10 μg/ml) for 30 min and then coincubation with L. rhamnosus GG strains for 3 h. Bacteria were administered at a ratio of 1:50 of cells to bacteria. The results are mean values ± standard deviations from three separate experiments. The values are normalized against those for GAPDH. Asterisks denote statistically significant differences from the results for the control (no antibody treatment).

    Article Snippet: The blocking monoclonal anti-human/mouse CD282 TLR2 purified antibody (clones T2.5 and 6C2) and monoclonal anti-mouse CD11b purified antibody (clone M1/70) were obtained from eBioscience (San Diego, CA, USA).

    Techniques: Standard Deviation, Expressing, Bacteria, Control